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THE DEVELOPMENT OF A NOVEL THERAPEUTIC FOR THE TREATMENT OF
SICKLE CELL DISEASE

Cody Wynn and Brian Brennan*
Chemistry Department, Illinois Wesleyan University

Sickle Cell Disease is a genetic blood disorder caused by a point mutation in the gene which
codes for hemoglobin in red blood cells. This mutation in the protein leads to the formation of
long polymeric strands of hemoglobin that cause the red blood cells to misform into the
characteristic sickled shape. These sickled red blood cells are too large to fit through capillaries
and thus cause the problems associated with sickle cell disease such as anemia and tissue
damage. Our approach towards developing novel therapeutics involves the production and
screening of large libraries of small peptides which target the point mutation in an effort to
discover ligands for the protein. Once ligands have been identified, we can determine if their
interactions are sufficient to prevent protein polymerization. We will present some recent
progress that we have made on this challenging biochemical problem.

